Evaluation of Repotrectinib's Anti-MM Effects in Combination with Bortezomib, Carfilzomib, Cyclophosphamide, and Dexamethasone in Vitro and Ex Vivo
Chen, Haiming, Souther, Eric, Li, Mingjie, Goldwater, Marissa-Skye, Behare, Stacy, Hekmati, Ava, Yu, Huixin, Nassir, Isabella, Nassir, Ariella, Xu, Ning, Berenson, James R.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
The JAK Inhibitor Pacritinib Suppresses the Checkpoint Proteins Pvrig and Tigit Expression on T Cells in Multiple Myeloma Patients
Xu, Ning, Li, Mingjie, Goldwater, Marissa-Skye, Behare, Stacy, Hekmati, Ava, Yu, Huixin, Nassir, Isabella, Nassir, Ariella, Deighton, Charles David, Chen, Haiming, Berenson, James R.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Ruxolitinib Enhances Anti-MM Function of Cytotoxic T-Cells By Upregulating IFNγ and Gzmb
Chen, Haiming, Li, Mingjie, Goldwater, Marissa-Skye, Behare, Stacy, Hekmati, Ava, Yu, Huixin, Nassir, Isabella, Nassir, Ariella, Deighton, Charles David, Xu, Ning, Berenson, James R.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Repotrectinib Alone and in Combination with Immunomodulatory Drugs Exhibits Potent Anti-Multiple Myeloma Activity
Chen, Haiming, Souther, Eric, Li, Mingjie, Goldwater, Marissa-Skye, Behare, Stacy, Hekmati, Ava, Yu, Huixin, Nassir, Isabella, Nassir, Ariella, Xu, Ning, Berenson, James R.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article